Lineage Cell Therapeutics Inc. Logo

Lineage Cell Therapeutics Inc.

Develops allogeneic cell therapies from stem cells for degenerative diseases.

LCTX | TA

Overview

Corporate Details

ISIN(s):
US53566P1093
LEI:
Country:
Israel
Address:
Derech Menachem Begin 121, 6701203 Tel Aviv

Description

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel allogeneic cell therapies for unmet medical needs. The company's proprietary platform uses directed differentiation of pluripotent stem cells to manufacture specialized human cells. These "off-the-shelf" cell transplants are designed to replace or support dysfunctional cells in patients with serious conditions, aiming to restore or enhance physiological function. The therapeutic pipeline is focused on degenerative diseases of the eye, such as dry age-related macular degeneration, and neurological conditions, including spinal cord injury. The company leverages its integrated capabilities in cell line development, manufacturing, and delivery to advance its programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 17:05
8-K
English 50.3 KB
2025-11-24 12:49
8-K
English 50.5 KB
2025-11-15 00:12 English 9.3 KB
2025-11-12 15:25
8-K
English 48.4 KB
2025-11-12 15:15
424B3
English 64.8 KB
2025-11-09 07:46
Immediate Report
English 102.5 KB
2025-11-09 07:46
Immediate Report
English 36.6 KB
2025-11-06 22:18
10-Q
English 1.8 MB
2025-11-06 22:12
8-K
English 155.1 KB
2025-09-26 17:52 English 7.7 KB
2025-09-24 22:39 English 7.2 KB
2025-09-10 23:31 English 7.0 KB
2025-09-08 20:22
Immediate Report
English 30.9 KB
2025-09-08 20:22
Immediate Report
English 36.5 KB
2025-08-26 15:14
8-K
English 135.8 KB

Automate Your Workflow. Get a real-time feed of all Lineage Cell Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Lineage Cell Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Lineage Cell Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cogent Biosciences, Inc. Logo
A clinical-stage biotech company developing precision therapies for genetic diseases.
United States of America
COGT
Coherus Oncology, Inc. Logo
Biopharmaceutical company developing and commercializing immuno-oncology therapies.
United States of America
CHRS
COLLEGIUM PHARMACEUTICAL, INC Logo
A biopharmaceutical company developing abuse-deterrent pain management medications.
United States of America
COLL
CollPlant Biotechnologies Ltd Logo
Develops plant-derived collagen for 3D bioprinting of tissues and organs.
United States of America
CLGN
COMPASS Pathways plc Logo
Develops psilocybin treatments for difficult-to-treat mental health conditions.
United States of America
CMPS
Compass Therapeutics, Inc. Logo
Clinical-stage biopharma developing antibody-based therapeutics for oncology.
United States of America
CMPX
Connect Biopharma Holdings Ltd Logo
A clinical-stage biopharma developing therapies for T cell-driven inflammatory diseases.
United States of America
CNTB
Context Therapeutics Inc. Logo
Clinical-stage biopharma developing T cell engaging bispecific antibodies for solid tumors.
United States of America
CNTX
Contineum Therapeutics, Inc. Logo
Clinical-stage biopharma developing oral small molecule therapies for NI&I conditions.
United States of America
CTNM
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage biopharma developing targeted therapies for oncology and obesity.
United States of America
CRBP

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.